Država: Južnoafrička Republika
Jezik: engleski
Izvor: South African Health Products Regulatory Authority (SAHPRA)
Ranbaxy (SA) (Pty) Ltd
See ingredients
INJECTION
EACH 1,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM 100,0 mg
Registered
1.3.2 Page 1 of 8 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S4 SUMABID 100 IV 100 mg/mL solution for injection (sugammadex) (Sugar free) This product contains 9,7 mg sodium (see section 6) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN SUMABID. Keep this leaflet. You may need to read it again. If you have further questions, please ask your doctor, pharmacist, nurse or other health care provider. WHAT IS IN THIS LEAFLET 1. What SUMABID is and what it is used for 2. What you need to know before you are given SUMABID 3. How to use SUMABID 4. Possible side effects 5. How to store SUMABID 6. Contents of the pack and other information 1. WHAT SUMABID IS AND WHAT IT IS USED FOR WHAT SUMABID IS SUMABID contains the active substance sugammadex. Sugammadex is considered to be a _Selective Relaxant Binding Agent _since it only works with specific muscle relaxants, rocuronium bromide or vecuronium bromide. WHAT SUMABID IS USED FOR 1.3.2 Page 2 of 8 When you have some types of operations, your muscles must be completely relaxed. This makes it easier for the surgeon to do the operation. For this, the general anaesthetic you are given includes medicines to make your muscles relax. These are called _ muscle relaxants_, and examples include rocuronium bromide and vecuronium bromide. Because these medicines also make your breathing muscles relax, you need help to breathe (artificial ventilation) during and after your operation until you can breathe on your own again. Sugammadex is used to speed up the recovery of your muscles after an operation to allow you to breathe on your own again earlier. It does this by combining with the rocuronium bromide or vecuronium bromide in your body. It can be used in adults whenever rocuronium bromide or vecuronium bromide is used and in children and adolescents (aged ≥7 years) when rocuronium bromide is used for a moderate level of relaxation. 2. WHAT YOU NEED TO KNOW BEFORE SUMABID IS GIVEN TO YOU SUMABID should not be given to you: If you are hypersensitive (allergic Pročitajte cijeli dokument
Page 1 of 15 PROFESSIONAL INFORMATION SCHEDULING STATUS S4 1. NAME OF THE MEDICINE SUMABID 100 IV 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each mL contains sugammadex (as octasodium) equivalent to 100 mg sugammadex. Each 2mL vial contains sugammadex (as octasodium) equivalent to 200 mg sugammadex Each mL contains up to 9,7 mg sodium (see section 4.4) For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for Injection. Clear, colourless to slightly yellow brown solution, practically free from particles in a colourless type I glass (2 mL) vial with a rubber stopper and alu-cap with orange flip top. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS SUMABID is indicated for the routine reversal of neuromuscular blockade induced by rocuronium or vecuronium. SUMABID is also indicated for the immediate reversal of neuromuscular blockade at 3 minutes after administration of rocuronium. For the paediatric population, SUMABID is only recommended for routine reversal of rocuronium induced blockade in children above 7 years of age. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY SUMABID injection should be administered under the supervision of an anaesthetist. SUMABID injection should be administered intravenously as a single bolus injection. The bolus injection may be given rapidly, within 10 seconds, directly into a vein or into an existing IV line. SUMABID can be injected into the intravenous line of a running infusion with the following intravenous solutions: Sodium chloride 9 mg/mL (0,9 %), glucose 50 mg/mL (5 %), sodium chloride 4,5 mg/mL (0,45 %) and glucose 25 mg/mL (2,5 %), Ringer's lactate solution, Ringer's solution, glucose 50 mg/mL (5 %) in sodium chloride 9 mg/mL (0,9 %). For paediatric patients SUMABID can be diluted using sodium chloride 9 mg/mL (0,9 %) to a concentration of 10 mg/mL. Page 2 of 15 Sugammadex has only been administered as a single bolus injection in reported clinical studies. The use of an appropriate neuromuscular monitoring technique is recommended to moni Pročitajte cijeli dokument